Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Control group outcomes in randomized trials of psilocybin indicated less improvement in depression scores compared with ...

The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in pregnancy.

A new review of research on 64 herbal remedies and dietary supplements for depression found ‘substantive’ evidence that only ...

Long-term stress can drain the color out of everything-sweet drinks taste bland and friends feel like strangers. According to ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not easing — the nation’s depression rates.

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...